Free Trial

Decibel Cannabis (DB) Stock Forecast & Price Target

Decibel Cannabis logo
C$0.12 +0.01 (+4.17%)
As of 03:24 PM Eastern

Decibel Cannabis - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
1
Buy
0

Based on 1 Wall Street analysts who have issued ratings for Decibel Cannabis in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for DB.

Consensus Price Target

C$0.10
-20.00% Downside
According to the 1 analysts' twelve-month price targets for Decibel Cannabis, the average price target is C$0.10. The highest price target for DB is C$0.10, while the lowest price target for DB is C$0.10. The average price target represents a forecasted downside of -20.00% from the current price of C$0.13.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for DB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Decibel Cannabis and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DB Analyst Ratings Over Time

TypeCurrent Forecast
5/5/25 to 5/5/26
1 Month Ago
4/5/25 to 4/5/26
3 Months Ago
2/4/25 to 2/4/26
1 Year Ago
5/5/24 to 5/5/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
1 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
N/A
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
N/A
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
N/A
0 Sell rating(s)
Consensus Price TargetC$0.10C$0.10N/AC$0.28
Forecasted Upside-20.00% Downside-20.00% DownsideN/A335.90% Upside
Consensus RatingHoldHoldN/AStrong Buy

DB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Decibel Cannabis Stock vs. The Competition

TypeDecibel CannabisMedical Companies
Consensus Rating Score
2.00
2.30
Consensus RatingHoldHold
News Sentiment Rating
Neutral News

See Recent DB News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
2/24/2026
TD Securities logo
TD Securities
4 of 5 stars
 Set TargetHoldC$0.10
8/15/2024 Lower TargetC$0.50 ➝ C$0.40+699.86%
8/15/2024
Ventum Financial logo
Ventum Financial
5 of 5 stars
 Lower TargetC$0.25 ➝ C$0.20+299.94%
5/30/2024Lower TargetSpeculative BuyC$0.30 ➝ C$0.25+257.11%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:28 AM ET.


DB Forecast - Frequently Asked Questions

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Decibel Cannabis is C$0.10, with a high forecast of C$0.10 and a low forecast of C$0.10.

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Decibel Cannabis in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DB, but not buy additional shares or sell existing shares.

According to analysts, Decibel Cannabis's stock has a predicted downside of -20.00% based on their 12-month stock forecasts.

Decibel Cannabis has been rated by research analysts at TD Securities in the past 90 days.

Analysts like Decibel Cannabis less than other "medical" companies. The consensus rating score for Decibel Cannabis is 2.00 while the average consensus rating score for "medical" companies is 2.30. Learn more on how DB compares to other companies.

Brokerages With Decibel Cannabis Recommendations


This page (CVE:DB) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners